In the News

Novartis To Pay $12.3M, Royalties To End IP Row With Juno

Monday, April 6, 2015

Novartis Pharmaceuticals Corp. will pay $12.25 million and royalties to Juno Therapeutics Inc. to settle a three-year-old patent dispute over cancer immunotherapy drugs between a university and a hospital with which they struck licensing deals, the parties said on Monday.

Morgan Lewis represents University of Pennsylvania in this matter.

Read the full Law360 story >>